×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Spain Minimally Invasive Surgery Devices Market

ID: MRFR/HC/49068-HCR
200 Pages
Rahul Gotadki
October 2025

Spain Minimally Invasive Surgery Devices Market Research Report By Application (General Surgery, Cardiothoracic Surgery, Gynecological Surgery, Urological Surgery, Orthopedic Surgery), By Product Type (Endoscopes, Robotic Surgery Systems, Laparoscopic Surgical Instruments, Visualization Systems, Access Devices), By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and By Technology (Video-Assisted Thoracoscopic Surgery, Transcatheter Aortic Valve Replacement, Natural Orifice Transluminal Endoscopic Surgery)-Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Spain Minimally Invasive Surgery Devices Market Infographic
Purchase Options

Spain Minimally Invasive Surgery Devices Market Summary

As per MRFR analysis, the minimally invasive-surgery-devices market Size was estimated at 383.85 USD Million in 2024. The minimally invasive-surgery-devices market is projected to grow from 419.16 USD Million in 2025 to 1010.88 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 9.2% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Spain minimally invasive-surgery-devices market is poised for substantial growth driven by technological advancements and increasing patient demand.

  • Technological advancements in surgical devices are enhancing the efficacy and safety of minimally invasive procedures.
  • The demand for outpatient procedures is growing, reflecting a shift towards more efficient healthcare delivery models.
  • The largest segment in this market is laparoscopic devices, while robotic-assisted surgical devices are the fastest-growing segment.
  • Key market drivers include the rising prevalence of chronic diseases and increasing healthcare expenditure, which are fueling the adoption of minimally invasive techniques.

Market Size & Forecast

2024 Market Size 383.85 (USD Million)
2035 Market Size 1010.88 (USD Million)

Major Players

Medtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Olympus Corporation (JP), Smith & Nephew (GB), Intuitive Surgical (US)

Spain Minimally Invasive Surgery Devices Market Trends

The minimally invasive surgery devices market is experiencing notable growth. This growth is driven by advancements in technology and increasing demand for less invasive surgical options. In Spain, healthcare providers are increasingly adopting these devices due to their potential to reduce recovery times and minimize patient discomfort. Innovative technologies, such as robotics and imaging systems, are enhancing the precision and effectiveness of surgical procedures. Furthermore, the Spanish government is actively promoting initiatives aimed at improving healthcare infrastructure, which may further bolster the adoption of minimally invasive techniques. Moreover, The rising prevalence of chronic diseases in Spain is contributing to the expansion of the minimally invasive surgery devices market. As the population ages, there is a growing need for surgical interventions that are less traumatic and offer quicker recovery. This trend is likely to encourage investment in research and development, leading to the introduction of new devices tailored to meet the specific needs of patients. Overall, The landscape appears promising, with various factors indicating a robust future for the minimally invasive surgery devices market in Spain.

Technological Advancements

The minimally invasive-surgery-devices market is witnessing rapid technological innovations. Enhanced imaging techniques and robotic-assisted surgeries are becoming more prevalent, allowing for greater precision and improved outcomes. These advancements are likely to attract more healthcare facilities to adopt minimally invasive methods.

Growing Demand for Outpatient Procedures

There is an increasing preference for outpatient surgical procedures among patients and healthcare providers. Minimally invasive techniques often allow for same-day discharge, which is appealing to both parties. This trend may lead to a higher adoption rate of minimally invasive devices in surgical practices.

Regulatory Support and Funding

The Spanish government is providing support for the development and implementation of minimally invasive surgical technologies. Initiatives aimed at enhancing healthcare services may include funding for research and development, which could stimulate growth in the minimally invasive-surgery-devices market.

Spain Minimally Invasive Surgery Devices Market Drivers

Increasing Healthcare Expenditure

Spain's rising healthcare expenditure is a significant driver for the minimally invasive-surgery-devices market. The government is increasing its investment in healthcare infrastructure, including the procurement of advanced surgical devices. In 2025, healthcare spending is expected to reach approximately €200 billion, reflecting a commitment to improving healthcare services. This financial support enables hospitals and surgical centers to adopt cutting-edge minimally invasive technologies, which are often more cost-effective in the long run due to shorter recovery times and reduced complications. Consequently, this trend is likely to bolster the market for minimally invasive surgical devices.

Supportive Regulatory Environment

The regulatory landscape in Spain is becoming increasingly favorable for the minimally invasive surgery devices market. Regulatory bodies are streamlining the approval processes for new surgical devices, which encourages innovation and market entry. Recent initiatives aimed at expediting the review of minimally invasive technologies are likely to enhance the availability of advanced surgical options. Furthermore, the Spanish government is actively promoting the adoption of minimally invasive techniques through various healthcare policies. This supportive environment not only fosters competition among manufacturers but also ensures that patients have access to the latest surgical advancements, thereby propelling market growth.

Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases in Spain is a pivotal driver for the minimally invasive surgery devices market. Conditions such as cardiovascular diseases, diabetes, and obesity necessitate surgical interventions, which are increasingly performed using minimally invasive techniques. According to recent health statistics, chronic diseases account for approximately 70% of all deaths in Spain, highlighting the urgent need for effective treatment options. This trend is likely to propel the demand for advanced surgical devices that minimize patient recovery time and reduce hospital stays. As healthcare providers seek to improve patient outcomes, the adoption of minimally invasive procedures is expected to rise, thereby expanding the market for these devices.

Technological Innovations in Surgical Devices

Technological advancements play a crucial role in shaping the minimally invasive-surgery-devices market. Innovations such as robotic-assisted surgery, advanced imaging techniques, and enhanced surgical instruments are transforming surgical practices in Spain. The integration of artificial intelligence and machine learning into surgical devices is gaining traction and may improve precision and outcomes. The market for surgical robots alone is projected to reach €1.5 billion by 2026, indicating a robust growth trajectory. These innovations not only enhance the capabilities of surgeons but also improve patient safety and satisfaction, thereby driving the overall market growth.

Patient Preference for Less Invasive Procedures

There is a notable shift in patient preferences towards less invasive surgical options, which is significantly influencing the minimally invasive-surgery-devices market. Patients are increasingly aware of the benefits associated with minimally invasive procedures, such as reduced pain, shorter recovery times, and minimal scarring. Surveys indicate that over 80% of patients prefer minimally invasive options when available. This growing demand is prompting healthcare providers in Spain to expand their offerings of such procedures, thereby driving the market for related surgical devices. As patient education continues to improve, this trend is expected to strengthen further.

Market Segment Insights

By Application: General Surgery (Largest) vs. Urological Surgery (Fastest-Growing)

In the Spain minimally invasive-surgery-devices market, General Surgery holds the largest market share, reflecting its widespread applicability and acceptance in various medical procedures. This segment benefits from the high volume of surgical procedures, which reinforces its dominance within the market. Following closely, Gynecological Surgery and Cardiothoracic Surgery also maintain significant shares, showcasing the robust demand for minimally invasive methods across diverse surgical practices. Growth trends reveal that Urological Surgery is emerging as the fastest-growing segment in the Spain minimally invasive-surgery-devices market. This surge is driven by technological advancements and an increase in the prevalence of urological conditions necessitating surgical interventions. Moreover, the rising awareness of the benefits of minimally invasive techniques is promoting their adoption in urological surgeries, contributing to the rapid growth of this segment.

General Surgery: Dominant vs. Urological Surgery: Emerging

General Surgery's dominance in the Spain minimally invasive-surgery-devices market arises from its applicability to a wide range of procedures, making it a cornerstone of surgical practice. Facilities are increasingly adopting these devices to enhance patient outcomes. Conversely, Urological Surgery, characterized by its innovative approaches to treat conditions such as kidney stones and prostate issues, is rapidly gaining traction. This segment is driven by the introduction of state-of-the-art technologies, which improve procedural efficacy and recovery times for patients. The combination of persistent demand and technological innovations positions Urological Surgery as a compelling emerging segment, promising significant growth potential in the upcoming years.

By Product Type: Endoscopes (Largest) vs. Robotic Surgery Systems (Fastest-Growing)

In the Spain minimally invasive-surgery-devices market, the market share distribution reveals that endoscopes represent the largest segment, attributed to their versatile applications in diagnostics and surgical procedures. Following closely are laparoscopic surgical instruments and visualization systems, which also hold substantial shares due to their critical roles in enhancing surgical outcomes. Access devices hold a smaller yet significant position, indicating a growing awareness among healthcare providers about efficient access techniques. The growth trends in this segment are primarily driven by technological advancements and the increasing adoption of minimally invasive methods. Robotic surgery systems have emerged as the fastest-growing segment, reflecting a shift towards precision and automation in surgical procedures. The rise in demand for improved patient outcomes and reduced recovery times further propels the market as surgeons and healthcare facilities increasingly invest in advanced surgical technologies.

Endoscopes (Dominant) vs. Robotic Surgery Systems (Emerging)

Endoscopes are the dominant segment in the Spain minimally invasive-surgery-devices market, known for their ability to provide real-time visualization and access to internal organs with minimal incisions. Their extensive use in gastroenterological and pulmonary procedures highlights their versatility and reliability. In contrast, robotic surgery systems are emerging as a significant player, offering enhanced precision and control during complex procedures and gaining traction among healthcare professionals. This segment benefits from rapid technological innovations, leading to improvements in surgical efficacy and patient safety. As healthcare providers increasingly recognize the advantages of these advanced systems, robotic surgery is anticipated to witness a robust growth trajectory, complementing traditional endoscopic approaches.

By End-use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Spain minimally invasive-surgery-devices market, hospitals hold the largest market share, benefiting from comprehensive surgical services and the availability of advanced medical technologies. Their substantial volume of surgeries performed contributes to their dominance within the sector. In contrast, ambulatory surgical centers have been gaining traction, showcasing significant growth due to the increasing shift towards outpatient procedures and patient preference for less invasive options. The expansion of ambulatory surgical centers is primarily driven by factors such as cost-effectiveness, enhanced patient convenience, and the rising prevalence of chronic diseases necessitating surgical interventions. As healthcare policies evolve to support outpatient surgeries, the growth rate for these facilities is expected to outpace traditional hospitals. Specialty clinics are also relevant, but their share and growth rate currently lag behind the other segments.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals represent the dominant force in the Spain minimally invasive-surgery-devices market, owing to their ability to cater to a wide range of surgical needs with state-of-the-art equipment and specialized staff. Their infrastructure supports complex surgeries and emergency procedures, which attracts a significant patient base. In contrast, ambulatory surgical centers, classified as emerging, capitalize on the demand for outpatient treatments. These centers are lauded for their efficiency, lower overhead costs, and shorter recovery times compared to traditional hospital settings. As patients increasingly seek alternatives that provide high-quality care with minimal disruption, ambulatory surgical centers are poised to expand their influence in the surgical landscape.

By Technology: Video-Assisted Thoracoscopic Surgery (Largest) vs. Transcatheter Aortic Valve Replacement (Fastest-Growing)

In the Spain minimally invasive-surgery-devices market, Video-Assisted Thoracoscopic Surgery represents the largest share due to its wide acceptance and effectiveness in treating thoracic conditions. This segment has gained a significant foothold among clinicians and hospitals for its minimally invasive approach, leading to quicker recovery times for patients. Following closely is Transcatheter Aortic Valve Replacement, which is rapidly growing in demand as an innovative solution for aortic valve diseases, catering to the aging population and enhancing patient outcomes. Growth trends indicate a robust future for both segment values, primarily driven by advancements in technology and increasing awareness among healthcare providers. The integration of enhanced imaging and navigation systems in Video-Assisted Thoracoscopic Surgery continues to attract attention, enabling more precision in procedures. Meanwhile, the rising incidence of cardiovascular diseases has positioned Transcatheter Aortic Valve Replacement as a key player, significantly boosting its adoption in clinical settings as new generations of devices are introduced.

Technology: Video-Assisted Thoracoscopic Surgery (Dominant) vs. Transcatheter Aortic Valve Replacement (Emerging)

Video-Assisted Thoracoscopic Surgery is characterized by its ability to perform complex thoracic surgeries through small incisions, minimizing pain and recovery time for patients. As a dominant technology in the segment, it has established a strong reputation for facilitating quicker discharges from hospitals and reducing the risk of complications post-surgery. Conversely, Transcatheter Aortic Valve Replacement, while emerging, shows substantial promise with its innovative approach that allows for heart valve replacements without open-heart surgery. This technique appeals to high-risk patients unable to undergo conventional procedures, making it an attractive option in the evolving landscape of minimally invasive therapies in the Spain minimally invasive-surgery-devices market.

Get more detailed insights about Spain Minimally Invasive Surgery Devices Market

Key Players and Competitive Insights

The minimally invasive-surgery-devices market in Spain is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for patient-centric healthcare solutions. Major players such as Medtronic (US), Johnson & Johnson (US), and Boston Scientific (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on innovation through continuous product development, particularly in robotic-assisted surgery, while Johnson & Johnson (US) emphasizes strategic partnerships to expand its portfolio in surgical instruments. Boston Scientific (US) appears to be leveraging its strong research capabilities to introduce novel therapies, thereby shaping a competitive environment that prioritizes innovation and collaboration.

Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The competitive structure is moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and services, catering to various surgical needs and preferences, while also fostering competition that drives innovation.

In October 2025, Medtronic (US) announced the launch of its latest robotic surgical system, which integrates advanced AI capabilities to improve surgical precision. This strategic move is significant as it positions Medtronic (US) as a leader in the robotic surgery segment, potentially increasing its market share and enhancing patient outcomes through improved surgical techniques. The introduction of AI in surgical procedures may also set a new standard for operational efficiency in the industry.

In September 2025, Johnson & Johnson (US) expanded its partnership with a leading Spanish healthcare provider to enhance the distribution of its minimally invasive surgical devices. This collaboration is crucial as it not only strengthens Johnson & Johnson's (US) foothold in the Spanish market but also facilitates access to innovative surgical solutions for healthcare professionals, thereby improving patient care. Such partnerships are indicative of a broader trend towards localized strategies that cater to specific market needs.

In August 2025, Boston Scientific (US) acquired a Spanish startup specializing in advanced imaging technologies for minimally invasive procedures. This acquisition is likely to enhance Boston Scientific's (US) product offerings and technological capabilities, allowing for more precise and effective surgical interventions. The integration of advanced imaging solutions could significantly improve surgical outcomes and patient safety, reflecting a growing trend towards the incorporation of cutting-edge technology in surgical practices.

As of November 2025, the competitive trends in the minimally invasive-surgery-devices market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding their market reach. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on technological advancements, innovative solutions, and reliable supply chains. This transition underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the market.

Key Companies in the Spain Minimally Invasive Surgery Devices Market market include

Industry Developments

The Spain Minimally Invasive Surgery Devices Market has seen notable advancements recently, particularly with key players such as Ethicon, Boston Scientific, Medtronic, and Hologic actively expanding their product offerings and market presence. In October 2023, Medtronic announced the launch of a new product line specifically targeting minimally invasive surgical procedures, further enhancing the technological landscape in Spain. Additionally, Johnson and Johnson has reported a growth in market valuation due to increased demand for surgical devices, reflecting ongoing healthcare investments in the region.

Noteworthy merger and acquisition activities include the acquisition of a surgical instruments division by Stryker in September 2023, which aligns with the growing trend of consolidation in the market. This strategic move aims to enhance Stryker's product portfolio and strengthen its foothold in Spain. Over the past couple of years, the market has been bolstered by government initiatives promoting advanced healthcare technologies, with Spain's healthcare budget reported to increase by 5% in 2022, fostering innovation in minimally invasive surgical devices.

This dynamic environment illustrates significant growth potential and ongoing investment in the industry, indicating an optimistic outlook for revenues and market evolution.

 

Future Outlook

Spain Minimally Invasive Surgery Devices Market Future Outlook

The minimally invasive-surgery-devices market in Spain is projected to grow at a 9.2% CAGR from 2024 to 2035, driven by technological advancements and increasing patient demand.

New opportunities lie in:

  • Development of AI-driven surgical assistance tools
  • Expansion of telemedicine platforms for remote consultations
  • Investment in biodegradable surgical devices for sustainability

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

Spain Minimally Invasive Surgery Devices Market End-use Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Spain Minimally Invasive Surgery Devices Market Technology Outlook

  • Video-Assisted Thoracoscopic Surgery
  • Transcatheter Aortic Valve Replacement
  • Natural Orifice Transluminal Endoscopic Surgery

Spain Minimally Invasive Surgery Devices Market Application Outlook

  • General Surgery
  • Cardiothoracic Surgery
  • Gynecological Surgery
  • Urological Surgery
  • Orthopedic Surgery

Spain Minimally Invasive Surgery Devices Market Product Type Outlook

  • Endoscopes
  • Robotic Surgery Systems
  • Laparoscopic Surgical Instruments
  • Visualization Systems
  • Access Devices

Report Scope

MARKET SIZE 2024383.85(USD Million)
MARKET SIZE 2025419.16(USD Million)
MARKET SIZE 20351010.88(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)9.2% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledMedtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Olympus Corporation (JP), Smith & Nephew (GB), Intuitive Surgical (US)
Segments CoveredApplication, Product Type, End-use, Technology
Key Market OpportunitiesAdvancements in robotic-assisted surgery enhance precision and patient outcomes in the minimally invasive-surgery-devices market.
Key Market DynamicsRising demand for advanced minimally invasive surgery devices driven by technological innovations and evolving patient preferences in Spain.
Countries CoveredSpain

Leave a Comment

FAQs

What is the expected market size of the Spain Minimally Invasive Surgery Devices Market in 2024?

The Spain Minimally Invasive Surgery Devices Market is expected to be valued at 800.77 million USD in 2024.

What is the projected market value for the Spain Minimally Invasive Surgery Devices Market by 2035?

By 2035, the market is projected to reach a valuation of 1800.0 million USD.

What is the expected CAGR for the Spain Minimally Invasive Surgery Devices Market during the forecast period from 2025 to 2035?

The expected CAGR for the Spain Minimally Invasive Surgery Devices Market during the forecast period is 7.641%.

Which application segment is expected to dominate the Spain Minimally Invasive Surgery Devices Market?

The General Surgery segment is expected to dominate, valued at 300.0 million USD in 2024 and projected at 680.0 million USD by 2035.

What is the market size for Cardiothoracic Surgery within the Spain Minimally Invasive Surgery Devices Market in 2024?

The market size for Cardiothoracic Surgery is anticipated to be 200.0 million USD in 2024.

How much is the market for Gynecological Surgery devices expected to grow by 2035?

By 2035, the market for Gynecological Surgery devices is expected to grow to 350.0 million USD.

What is the expected market value of Urological Surgery devices in the Spain Minimally Invasive Surgery Devices Market in 2024?

The expected market value of Urological Surgery devices in 2024 is 100.0 million USD.

Who are the key players in the Spain Minimally Invasive Surgery Devices Market?

Major players in the market include Ethicon, Boston Scientific, Medtronic, Hologic, Johnson & Johnson, and Stryker.

What is the market size for Orthopedic Surgery devices in the Spain Minimally Invasive Surgery Devices Market in 2024?

The market size for Orthopedic Surgery devices is valued at 50.77 million USD in 2024.

What are the growth drivers for the Spain Minimally Invasive Surgery Devices Market?

Key growth drivers include advancements in technology and the increasing preference for minimally invasive procedures.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions